In normal mammary epithelial cells, LOXL2 overexpression induces oncogenic transformation and cancer progression by activating the Erb-B2 receptor tyrosine kinase 2 (ERBB2) through the production of reactive oxygen species (ROS) [108]. Here, LOXL2 is linked to cancer.